GSK3B and salivary gland cancer: In oral, laryngeal, esophageal and salivary gland cancer [14], breast cancer [36] phosphorylation on the inhibitory serine (GSK3β S9) was reported to be elevated and the activity of GSK3 was reasoned to be reduced as a result.